Click here for an accessible version of this site

How do I get the vaccine?

You can help protect your child’s life and dreams with Menactra vaccine. If your child is like other children, they probably see their doctor a lot less than they did when they were younger. That’s why it’s important to schedule a visit to see your doctor. Menactra vaccine can help protect your child against meningococcal disease (which includes meningitis). Talk to your doctor about vaccination today.

Ask your doctor about Menactra vaccine

Menactra vaccine can help protect your child against meningococcal disease.1-3 Here are some questions you should ask your child’s doctor concerning a Menactra vaccination:

"Has my child been vaccinated against meningococcal disease?"

If YES, then ask:

  • "When was my child vaccinated for meningococcal disease?"
  • "Is that vaccination still effective?"
  • "Are there any other steps I can take to protect my child from meningococcal disease?"

If NO, then ask:

  • "Why wasn’t my child vaccinated for meningococcal disease?"
  • "Isn’t the vaccine recommended by the Centers for Disease Control and Prevention (CDC)?"
  • "Can my child get the vaccination now?"
  • "Does our state legislation require getting the meningococcal vaccination to attend high school, summer camp, or college?"

What’s your story?

Share your personal experience with meningococcal disease and meningitis.

More Menactra vaccine information

Would you like us to send you more information about Menactra vaccine? Let us know if you want a brochure packet for yourself, or a few packets for an event.

Help for the underinsured and uninsured

If you’re underinsured or uninsured, your child can still get Menactra vaccine – for little or no fee.13

Indication
Menactra vaccine is given to persons 2 through 55 years of age for active immunization against invasive meningococcal disease caused by N meningitidis serogroups A, C, Y, and W-135. Menactra vaccine will not stimulate protection against infection caused by N meningitidis other than serogroups A, C, Y, and W-135.

Safety Information
Side effects to Menactra vaccine include injection site pain, redness, and swelling; headache or fatigue. Other side effects may occur. Vaccination should be avoided by persons with known hypersensitivity (severe allergic reaction) to any ingredient of the vaccine, including latex (which is used in the vial stopper), or by any persons previously diagnosed with Guillain-Barré syndrome. There is a potential for an increased chance of getting Guillain-Barré syndrome following vaccination. Vaccination with Menactra vaccine may not protect all individuals.

For more information about Menactra vaccine, talk to your health-care professional.